Abstract
In 104 patients with gastric cancer the serum proteins carcinoembryonic antigen (CEA), C-reactive protein (CRP), alpha 1-acid glycoprotein (AGP) (orosomucoid) and alpha 1-antichymotrypsin (ACT) were measured pre-operatively. The estimated median survival of patients with both raised CEA and ACT was only 5 weeks in contrast to 64 weeks for those with both proteins normal. An intermediary group with one of these proteins raised and the other normal had an estimated median survival of 15 weeks. Similar results were obtained by considering a combination of CEA with either AGP or CRP. For these data the results were not explicable in terms of associations between survival time and patient's age, stage, operative procedure, histological classification or site of primary tumour.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Rashid, S., O'Quigley, J., Axon, A. et al. Plasma protein profiles and prognosis in gastric cancer. Br J Cancer 45, 390–394 (1982). https://doi.org/10.1038/bjc.1982.66
Issue Date:
DOI: https://doi.org/10.1038/bjc.1982.66
- Springer Nature Limited
This article is cited by
-
Persistent elevated C-reactive protein after treatment is an independent marker of a poor prognosis in patients with hepatocellular carcinoma
Clinical and Translational Oncology (2013)
-
Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma
Medical Oncology (2012)
-
Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer
Surgery Today (2011)
-
Elevated tumour interleukin-1β is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancer
British Journal of Cancer (2006)